Skip to main content
. 2023 Oct 18;159(12):1332–1338. doi: 10.1001/jamadermatol.2023.3703

Table 2. Multivariable Analysis for Poor Outcomes.

Factor SHR (95% CI) P value
Local recurrence (n = 12)
Sex
Female 1 [Reference]
Male 9.82 (1.48-65.34) .02a
Differentiation
Well or moderate 1 [Reference]
Poor differentiation 2.81 (0.88-9.00) .08
PNI extent
Focal 1 [Reference]
Moderate 2.15 (0.42-10.90) .36
Extensive 13.83 (3.50-54.62) <.001a
Any metastasis (n = 10)
Depth
Limited to dermis/subcutaneous fat 1 [Reference]
Beyond subcutaneous fat 2.62 (0.74-9.30) .14
Differentiation
Well or moderate 1 [Reference]
Poor 5.04 (1.28-19.84) .02a
Disease-specific death (n = 11)
Age, y 0.94 (0.88-1.01) .12
Sex
Female 1 [Reference]
Male 8.39 (0.92-76.69) .06
PNI extent
Focal 1 [Reference]
Moderate 1.35 (0.32-5.73) .68
Extensive 6.20 (1.59-24.21) .009a
Any poor outcome (n = 17)
Depth
Limited to dermis/subcutaneous fat 1 [Reference]
Beyond subcutaneous fat 1.91 (0.69-5.29) .21
Sex
Female 1 [Reference]
Male 6.86 (1.45-32.39) .02a
Differentiation
Well or moderate 1 [Reference]
Poor 3.22 (1.22-8.47) .02a
PNI extent
Focal 1 [Reference]
Moderate 1.78 (0.47-6.74) .40
Extensive 10.21 (2.88-36.15) <.001a

Abbreviations: PNI, perineural invasion; SHR, subhazard ratio.

a

Statistically significant.